Question Of The Day

Question - What 1976 Act gave the EPA the authority to regulate chemical substances and mixtures that present an unreasonable risk of injury to health or the environment?

Question - Ceftriaxone is a third-generation cephalosporin with broad spectrum activity against both Gram-negative and Gram-positive bacteria. What potential toxicities have limited the use of this drug in neonatal patients?

Question - What characterizes cutaneous reactions to bed bug (Cimex lectularius) bites?

Question - Inhalational anthrax is a rare disease that can occur after exposure to infected animals or contaminated animal products, or as a result of an intentional release of anthrax spores. It is caused by breathing in the spores of the bacterium Bacillus anthracis. When inhaled, the anthrax bacteria replicate in the body and produce toxins that can cause massive and irreversible tissue injury and death. Anthrax is a potential bioterrorism threat because the spores are resistant to destruction and can be spread by release in the air. What drug has recently been approved as a new treatment for inhalation anthrax?

Question - The U.S. Food and Drug Administration recently warned about contamination with brodifacoum of which illegal, often abused, substances?

Question - In what industries might workers become exposed to dangerous levels of hydrogen sulfide?

Question - Workers at a lamp recycling facility may be at risk for the development of toxicity from what metal?

Question - What potentially catastrophic adverse effect has been associated with the administration of fluoroquinolones in persons over the age of 65 years.

Question - Since its resurgence as a drug used in the treatment of some cases severe sepsis reports of extravasation and skin necrosis due to vasopressin have appeared in the literature. What is the recommended treatment for vasopressin extravasation?

Question - Cisplatin is an antineoplastic drug that may be used in the treatment of a variety of solid organ cancers. What is the primary does-limiting toxicity associated with the use of this drug?